CONSORT 2025 statement: updated guideline for reporting randomised trials

Hopewell, Sally; Chan, An‐Wen; Gary S. Collins, Professor; Hróbjartsson, Asbjørn; Moher, David; F. Schulz, Kenneth; Tunn, R.; Aggarwal, Rakesh; Berkwits, Michael; A. Berlin, Jesse; Bhandari, Nita; J. Butcher, Nancy; Campbell, Marion; C.W. Chidebe, Runcie; Elbourne, Diana; Farmer, Andrew; Fergusson, Dean; M. Golub, Robert; N. Goodman, Steven; Hoffmann, Tammy; P. A. Ioannidis, John; C Kahan, Brennan; L Knowles, Rachel; E Lamb, Sarah; Lewis, Steff; Loder, Elizabeth; Offringa, Martin; Ravaud, Philippe; P. Richards, Dawn; W. Rockhold, Frank; L. Schriger, David; Siegfried, Nandi; Staniszewska, Sophie; Taylor, R.; Thabane, Lehana; Torgerson, David; Vohra, Sunita; R. White, Ian; Boutron, Isabelle

doi:10.1136/bmj-2024-081123

Public

CONSORT 2025 statement: updated guideline for reporting randomised trials

Published in BMJ • Apr 14, 2025

Authors:

Sally Hopewell

An‐Wen Chan

Professor Gary S. Collins

Abstract

BACKGROUND: Well designed and properly executed randomised trials are considered the most reliable evidence on the benefits of healthcare interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) stat...

Subject

Consolidated Standards of Reporting Trials

Guideline

Statement (logic)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!